Literature DB >> 4916537

Growth hormone dynamics in acromegaly.

A M Lawrence, I D Goldfine, L Kirsteins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4916537     DOI: 10.1210/jcem-31-3-239

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  18 in total

1.  Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.

Authors:  Pamela U Freda; Carlos M Reyes; Abu T Nuruzzaman; Robert E Sundeen; Jeffrey N Bruce
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

2.  Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.

Authors:  A Long; T Loughlin; R P Towers; T J McKenna
Journal:  Ir J Med Sci       Date:  1988-07       Impact factor: 1.568

3.  Pregnancy in an acromegalic after bromocriptine therapy.

Authors:  C O'Herlihy
Journal:  Ir J Med Sci       Date:  1980-07       Impact factor: 1.568

4.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 5.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

Review 6.  Changing concepts on the control of growth hormone secretion in man.

Authors:  W P VanderLaan
Journal:  Calif Med       Date:  1971-08

7.  Pituitary function and growth hormone dynamics in acromegaloidism.

Authors:  R B Mims
Journal:  J Natl Med Assoc       Date:  1978-12       Impact factor: 1.798

8.  Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma.

Authors:  E Ciccarelli; M R Valetto; E Vasario; T Avataneo; S Grottoli; F Camanni
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

9.  The effects of oral clonidine on the growth hormone level in acromegalic patients.

Authors:  L Gáspár; T Janáky; Z Valkusz; F A László
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

10.  Effect of fenfluramine on human growth hormone release.

Authors:  W R Sulaiman; R H Johnson
Journal:  Br Med J       Date:  1973-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.